| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 45.90B | 46.63B | 50.93B | 67.44B | 59.69B |
| Gross Profit | 7.28B | 7.61B | 8.24B | 10.81B | 9.14B |
| EBITDA | 2.30B | 2.93B | 3.34B | 5.01B | 3.64B |
| Net Income | 1.72B | 1.79B | 2.09B | 3.31B | 2.34B |
Balance Sheet | |||||
| Total Assets | 28.35B | 29.23B | 28.47B | 33.50B | 32.83B |
| Cash, Cash Equivalents and Short-Term Investments | 6.83B | 8.13B | 6.17B | 6.08B | 6.15B |
| Total Debt | 1.26B | 722.43M | 1.15B | 2.47B | 2.10B |
| Total Liabilities | 11.59B | 10.54B | 10.00B | 14.89B | 15.20B |
| Stockholders Equity | 16.76B | 18.69B | 18.47B | 18.61B | 17.63B |
Cash Flow | |||||
| Free Cash Flow | 1.52B | 3.90B | 3.71B | 2.01B | -472.81M |
| Operating Cash Flow | 1.53B | 3.94B | 3.79B | 2.90B | 426.21M |
| Investing Cash Flow | -1.98B | -30.33M | 28.58M | -897.98M | -696.80M |
| Financing Cash Flow | -843.13M | -1.96B | -3.74B | -2.09B | 497.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥26.87B | 15.94 | ― | 6.06% | -1.56% | 1.29% | |
74 Outperform | ¥136.12B | 7.94 | 8.07% | 2.64% | 81.06% | 65.92% | |
69 Neutral | ¥7.47T | 44.83 | 32.32% | 0.91% | 20.73% | 72.44% | |
68 Neutral | ¥2.96T | 40.85 | 10.06% | 1.21% | 8.80% | 117.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥57.58B | -90.64 | ― | 5.01% | -25.54% | -166.77% | |
58 Neutral | ¥46.12B | 10.44 | ― | 0.91% | 11.44% | -4.29% |